|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 109.33 USD | +1.39% |
|
+6.83% | +10.74% |
| 06-11 | Guggenheim Lifts Price Target on Incyte to $136 From $130, Maintains Buy Rating | MT |
| 06-11 | William O'Neil Initiates Incyte at Buy | MT |
Company Valuation: Incyte Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 16,213 | 17,869 | 14,072 | 13,306 | 19,391 | 21,543 | - | - |
| Change | - | 10.21% | -21.25% | -5.44% | 45.73% | 11.1% | - | - |
| Enterprise Value (EV) 1 | 13,865 | 14,630 | 10,416 | 11,148 | 16,293 | 16,560 | 14,713 | 12,720 |
| Change | - | 5.52% | -28.81% | 7.03% | 46.15% | 1.64% | -11.16% | -13.55% |
| P/E Ratio | 17.2x | 52.8x | 23.7x | 460x | 15.4x | 17.5x | 14.1x | 13.1x |
| PBR | 4.32x | 4.09x | 2.71x | 3.88x | 3.79x | 3.2x | 2.47x | 1.98x |
| PEG | - | -0.8x | 0.3x | -4.9x | 0x | -4.86x | 0.6x | 1.65x |
| Capitalization / Revenue | 5.43x | 5.26x | 3.81x | 3.14x | 3.77x | 3.83x | 3.45x | 3.28x |
| EV / Revenue | 4.64x | 4.31x | 2.82x | 2.63x | 3.17x | 2.94x | 2.36x | 1.94x |
| EV / EBITDA | 21.5x | 24.5x | 14.8x | 22.2x | 9.53x | 9.1x | 6.5x | 5.46x |
| EV / EBIT | 23.7x | 25.2x | 16.8x | 26.9x | 10.1x | 8.9x | 6.23x | 4.76x |
| EV / FCF | 24.4x | 16.4x | 22.4x | 44.8x | - | 11.4x | 8.66x | 7.24x |
| FCF Yield | 4.1% | 6.1% | 4.45% | 2.23% | - | 8.74% | 11.6% | 13.8% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 4.27 | 1.52 | 2.65 | 0.15 | 6.41 | 6.179 | 7.623 | 8.229 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,986 | 3,395 | 3,696 | 4,241 | 5,141 | 5,624 | 6,237 | 6,568 |
| EBITDA 1 | 643.6 | 597.7 | 703.2 | 503.1 | 1,709 | 1,819 | 2,264 | 2,331 |
| EBIT 1 | 585.8 | 579.4 | 620.5 | 413.9 | 1,616 | 1,861 | 2,363 | 2,670 |
| Net income 1 | 948.6 | 340.7 | 597.6 | 32.62 | 1,287 | 1,286 | 1,601 | 1,739 |
| Net Debt 1 | -2,348 | -3,239 | -3,656 | -2,158 | -3,098 | -4,982 | -6,830 | -8,823 |
| Reference price 2 | 73.40 | 80.32 | 62.79 | 69.07 | 98.77 | 107.83 | 107.83 | 107.83 |
| Nbr of stocks (in thousands) | 220,891 | 222,475 | 224,109 | 192,650 | 196,323 | 199,782 | - | - |
| Announcement Date | 08/02/22 | 07/02/23 | 13/02/24 | 10/02/25 | 10/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 17.45x | 2.94x | 9.1x | -.--% | 21.54B | |
| 15.83x | 3.42x | 9.23x | 0.64% | 62.21B | |
| 29.23x | 5.92x | 17.17x | 0.54% | 59.45B | |
| 31.79x | 10.74x | 20.27x | -.--% | 38.9B | |
| -48.35x | 2.94x | 8.68x | 3.8% | 36.4B | |
| 32.29x | 3.5x | 10.56x | -.--% | 29.52B | |
| -5.74x | 7.71x | -4.71x | -.--% | 19.7B | |
| 46.9x | 4.95x | 35.54x | -.--% | 16.18B | |
| 24.54x | 5.08x | 13.7x | -.--% | 15.89B | |
| -31.05x | 14.64x | -44.34x | -.--% | 13.23B | |
| Average | 11.29x | 6.19x | 7.52x | 0.5% | 31.3B | |
| Weighted average by Cap. | 13.27x | 5.63x | 10.61x | 0.67% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- INCY Stock
- Valuation Incyte Corporation
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition